Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart

Frontiers in Physiology

Volumn 6, Issue MAR, 2015, Pages

  Schlüter, Klaus Dieter ^a   Schulz, Rainer ^a   Schreckenberg, Rolf ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

Nitric oxide; Ornithine; Polyamines; Reactive oxygen species; Reperfusion injury

Indexed keywords

AMINO ACID TRANSPORTER; ARGINASE; ARGINASE 1; ARGINASE II; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; ORNITHINE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACTION POTENTIAL DURATION; AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ARTICLE; BINDING SITE; CALCIUM CURRENT; CARDIOVASCULAR RISK; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART ARRHYTHMIA; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HUMAN; NITROSYLATION; NONHUMAN; PATHOGENESIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84926466287     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00054     Document Type: Article

References (59)

1. Bagnost, T., Ma, L., da Silva, R. F., Rezakhaniha, R., Houdayer, C., Stergiopulos, N., et al. (2010). Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension. Cardiovasc. Res . 87, 569-577. doi: 10.1093/cvr/cvq081
2. Bogatzki, M. (1963). Argininstoffwechsel im hypertrophischen und hyperplastischen nierengewebe und im myokard bei arbeitshypertrophie des herzens infolge renalen hochdrucks. Zts. Ges. Exptl. Med . 137, 256-262. doi: 10.1007/BF02045500
3. Booz, G. W. (2005). Putting the brakes on cardiac hypertrophy. Hypertension 45, 341-346. doi: 10.1161/01.HYP.0000156878.17006.02
4. Cabrera-Fuentes, H. A., Ruiz-Meana, M., Simsekyilmaz, S., Kostin, S., Inserte, J., Saffarzadeh, M., et al. (2014). RNAse 1 prevents the damaging interplay between extracellular RNA and tumor necrosis factor-α in cardiac ischemia/reperfusion injury. Thromb. Haemost . 112, 1110-1119. doi: 10.1160/TH14-08-0703
5. Canton, M., Skyschally, A., Menabo, R., Boengler, K., Gres, P., Schulz, R., et al. (2006). Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization. Eur. Heart J . 27, 875-881. doi: 10.1093/eurheartj/ehi751
6. Chen, B., Xue, J., Meng, X., Slutzky, J. L., and Clavert, A. E. (2014). Resveratrol prevents hypoxia-induced arginase II expression and proliferation of human pulmonary artery smooth muscle cells via Akt-dependent signalling. Am. J. Physiol. Lung Cell. Mol. Physiol . 307, L317-L325. doi: 10.1152/ajplung.00285.2013
7. Erbas, H., Aydogdu, N., and Kaymak, K. (2004). Effects of N-aceytlcysteine on arginase, ornithine and nitric oxide in renal ischemia-reperfusion injury. Pharmacol. Res . 50, 523-527. doi: 10.1016/j.phrs.2004.04.005
8. Fischmeister, R., Castro, L., Abi-Gerges, A., Rochais, F., and Vandecasteele, G. (2005). Species- and tissue-dependent effects on NO and cyclic GMP on cardiav ion channels. Comp. Biochem. Physiol. A Mol. Integr. Physiol . 142, 136-143. doi: 10.1016/j.cbpb.2005.04.012
9. Gao, X., Xu, X., Belmadani, S., Park, Y., Tang, Z., Feldman, A. M., et al. (2007). TNF-α contributes to endothelial dysfunction by upregulating arginase in ischemic/reperfusion injury. Arterioscler. Thromb. Vasc. Biol . 27, 1269-1275. doi: 10.1161/ATVBAHA.107.142521
10. Giordano, E., Flamigni, F., Guarnieri, C., Muscari, C., Pignatti, C., Stefanelli, C., et al. (2010). Polyamine in cardiac physiology and disease. Open Heart Fail. J . 3, 25-30. doi: 10.2174/1876535101003020025
11. Gonon, A. T., Jung, C., Katz, A., Westerblad, H., Shemyakin, A., Sjoquist, P. O., et al. (2012). Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production. PLoS ONE 7:e42038. doi: 10.1371/journal.pone.0042038
12. Grönros, J., Kiss, A., Palmer, M., Jung, C., Berkowitz, D., and Pernow, J. (2013). Arginase inhibition improves corornary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model. Acta Physiol . 208, 172-179. doi: 10.1111/apha.12097
13. Harpster, M. H., Bandyopadhyay, S., Thomas, D. P., Ivanov, P. S., Keele, J. A., Pineguinea, N., et al. (2006). Earliest changes in the left ventricular transcriptome post-myocardialk infarction. Mamm. Genome 17, 701-715. doi: 10.1007/s00335-005-0120-1
14. Hearse, D. J., Humphrey, S. M., and Chain, E. B. (1973). Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J. Mol. Cell. Cardiol . 5, 395-407. doi: 10.1016/0022-2828(73)90030-8
15. Hein, T. W., Zhang, C., Wang, W., Chang, C.-I., Thengchaisri, N., and Kuo, L. (2003). Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J . 17, 2328-2330. doi: 10.1096/fj.03-0115fje
16. Heusch, P., Aker, S., Boengler, K., Deindl, E., van de Sand, A., Klein, K., et al. (2010). Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation. Am. J. Physiol . 299, H446-H553. doi: 10.1152/ajpheart.01034.2009
17. Jeyabalan, G., Klune, J. R., Nakao, A., Martik, N., Wu, G., Tsung, A., et al. (2008). Arginase blockade protects against hepatic damage in warm ischemia-reperfusion. Nitric Oxide 19, 29-35. doi: 10.1016/j.niox.2008.04.002
18. Jin, Y., Jin, Y., Chen, B., Tipple, T. E., and Nelin, L. D. (2014). Arginase II is a target of miR-17-5p and regulates miR17-5p expression in human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol . 307, L197-L204. doi: 10.1152/ajplung.00266.2013
19. Jung, C., Gonon, A. T., Sjöquist, P.-O., Lundberg, J. O., and Pernow, J. (2010). Arginase inhibition mediates cardioprotection during ischemia-reperfusion. Cardiovasc. Res . 85, 147-154. doi: 10.1093/cvr/cvp303
20. Kawano, K., Masuda, H., Yano, M., Kihara, K., Sugimoto, A., and Azuma, H. (2006). Altered nitric oxide synthase, arginase and ornithine decarboxylase activities, and polyamine synthesis in response to ischemia of the rabbit detrusor. J. Urol . 176, 387-393. doi: 10.1016/S0022-5347(06)00515-5
21. Kerem, M., Bedirli, A., Pasaoglu, H., Ofluglu, E., Yilmazer, D., Salman, B., et al. (2008). Effects of adrenomedullin on hepatic damage in hepatic ischaemia/reperfusion injury in rats. Liver Int . 28, 972-981. doi: 10.1111/j.1478-3231.2008.01741.x
22. Längle, F., Roth, E., Steininger, R., Winkler, S., and Mühlbacher, F. (1995). Arginase release following liver reperfusion. Transplantation 59, 1542-1549. doi: 10.1097/00007890-199506000-00007
23. Lee, S., Huen, S., Nishio, S., Lee, H. K., Choi, B.-S., Ruhrberg, C., et al. (2011). Distinct macrophage phenotypes contribute to kidney injury and repair. J. Am. Soc. Nephrol . 22, 317-326. doi: 10.1681/ASN.2009060615
24. Lu, M.-J., Chen, Y.-S., Huang, H.-S., and Ma, M.-C. (2012). Erythropoietin alleviates post-ischemic injury of rat hearts by attenuating nitrosative stress. Life Sci . 90, 776-784. doi: 10.1016/j.lfs.2012.04.012
25. Martens, C. R., Kuczmarski, J. M., Lennon-Edwards, S., and Edwards, D. G. (2014). Impaired L-arginine uptake but not arginase contributes to endothelial dysfunction in rats with chronic kidney disease. J. Cardiovasc. Pharmacol . 63, 40-48. doi: 10.1097/FJC.0000000000000022
26. Massion, P. B., Pelat, M., Belge, C., and Balligand, J.-L. (2005). Regulation of the mammalian heart function by nitric oxide. Comp. Biochem. Physiol. A Mol. Integr. Physiol . 142, 144-150 doi: 10.1016/j.cbpb.2005.05.048
27. Mochly-Rosen, D., Das, K., and Grimes, K. V. (2012). Protein kinase C, an elusive therapeutic target? Nat. Rev. Drug Discov . 11, 937-957. doi: 10.1038/nrd3871
28. Mörlein, C., Schreckenberg, R., and Schlüter, K.-D. (2010). Basal ornithine decarboxylase activity modifies apoptotic and hypertrophic marker expression in post-ischemic hearts. Open Heart Fail. J . 3, 31-37. doi: 10.2174/1876535101003020031
29. Morris, S. M. Jr. (2005). Arginine metabolism in vascular biology and disease. Vasc. Med . 10(Suppl 1), S83-S87. doi: 10.1177/1358836X0501000112
30. Ofluoglu, E., Kerem, M., Pasaoglu, H., Turkozkan, N., Seven, I., Bedirli, A., et al. (2006). Delayed energy protection of ischemic preconditioning on hepatic ischemia/reperfusion injury in rats. Eur. Surg. Res . 38, 114-121. doi: 10.1159/000093300
31. Pandey, D., Sikka, G., Bergman, Y., Kim, J. H., Ryoo, S., Romer, L., et al. (2014). Transcriptional regulation of endothelial arginase 2 by histone deacetylase 2. Arterioscler. Thromb. Vasc. Biol . 34, 1556-1566. doi: 10.1161/ATVBAHA.114.303685
32. Raghavachari, N., Xu, X., Harris, A., Villagra, J., Logun, C., Barb, J., et al. (2007). Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation 115, 1551-1562. doi: 10.1161/CIRCULATIONAHA.106.658641
33. Rassaf, T., Poll, L. W., Brouzos, P., Lauer, T., Totzeck, M., Kleinbongard, P., et al. (2006). Positive effects of nitric oxide on left ventricular function in humans. Eur. Heart J . 27, 1699-1705. doi: 10.1093/eurheartj/ehl096
34. ω-hydroxy-nor-L-arginine (nor-NOHA). Am. J. Physiol. Gastrointest. Liver Physiol . 292, G512-G517. doi: 10.1152/ajpgi.00227.2006
35. Romero, M. J., Platt, D. H., Caldwell, R. B., and Caldwell, R. W. (2006). Therapeutic use of citrulline in cardiovascular disease. Cardiovasc. Drug Rev . 24, 275-290. doi: 10.1111/j.1527-3466.2006.00275.x
36. Roth, E., Steininger, R., Winkler, S., Längle, F., Grünberger, T., Függer, R., et al. (1994). L-Arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Transplantation 57, 665-669. doi: 10.1097/00007890-199403150-00006
37. Roy, S., Biswas, S., Khanna, S., Gordillo, G., Bergdall, V., Green, J., et al. (2009). Characterization of a preclinical model of chronic ischemic wound. Physiol. Genomics 37, 211-224. doi: 10.1152/physiolgenomics.90362.2008
38. Ryoo, S., Gupta, G., Benjo, A., Lim, H. K., Camara, A., Sikka, G., et al. (2008). Endothelial arginase II: a novel target for the treatment of artherosclerosis. Circ. Res . 102, 923-932. doi: 10.1161/CIRCRESAHA.107.169573
39. Schlüter, K.-D., Frischkopf, K., Flesch, M., Rosenkranz, S., Taimor, G., and Piper, H. M. (2000). Central role for ornithine decarboxylase in Β-adrenoceptor mediated hypertrophy. Cardiovasc. Res . 45, 410-417. doi: 10.1016/S0008-6363(99)00351-X
40. Schreckenberg, R., Dyukova, E., Sitdikova, G., Abdallah, Y., and Schlüter, K.-D. (2015a). Mechanisms by which calcium receptor stimulation modifies electromechanical coupling in isolated ventricular cardiomyocytes. Pflugers Arch . 467, 379-388. doi: 10.1007/s00424-014-1498-y
41. Schreckenberg, R., Weber, P., Cabrera-Fuentes, H. A., Steinert, I., Preissner, K. T., Bencsik, P., et al. (2015b). Mechanism and consequences of the shift in cardiac arginine metabolism following ischemia and reperfusion in rats. Thromb. Haemost . 113, 482-493. doi: 10.1160/TH14-05-0477
42. Schulman, S. P., Becker, L. C., Kass, D. A., Champion, H. C., Terrin, M. L., Forman, S., et al. (2006). L-Arginine therapy in acute myocardial infarction. JAMA 295, 58-64. doi: 10.1001/jama.295.1.58
43. Schwartz, I. F., Schwartz, D., Traskonov, M., Chernikovsky, T., Wollman, Y., Gnessin, E., et al. (2002). L-Arginine transport is augmented through up-regulation of tubular CAT-2 mRNA in ischemic acute renal failure in rats. Kidney Int . 62, 1700-1706. doi: 10.1046/j.1523-1755.2002.t01-1-00622.x
44. Sharda, D. R., Yu, S., Ray, M., Squadrito, M. L., de Palma, M., Wynn, T. A., et al. (2011). Regulation of macrophage arginase expression and tumor growth by the ron receptor tyrosine kinase. J. Immunol . 187, 2181-2192. doi: 10.4049/jimmunol.1003460
45. Silva, M. A., Richards, D. A., Bramhall, S. R., Adams, D. H., Mirza, D. F., and Murphy, N. (2005). A study of the metabolites of ischemia-reperfusion injury and selected amino acids in the liver using microdialysis during transplantation. Transplantation 79, 828-835. doi: 10.1097/01.TP.0000153156.38617.97
46. Singh, M., Padhy, G., Vats, P., Bhargava, K., and Sethy, N. K. (2014). Hypobaric hypoxia induced arginase expression limits nitric oxide availability and signaling in rodent heart. Biochem. Biophys. Acta 1840, 1817-1824. doi: 10.1016/j.bbagen.2014.01.015
47. Smajilovic, S., Chattopadhyay, N., and Tfelt-Hansen, J. (2010). Calcium-sensing receptor in cardiac physiology. Open Heart Fail. J . 3, 11-15. doi: 10.2174/1876535101003020011
48. Smith, H. A. B., Canter, J. A., Christian, K. G., Drinkwater, D. C., Scholl, F. G., Christman, B. W., et al. (2006). Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J. Thorac. Cardiovasc. Surg . 132, 58-65. doi: 10.1016/j.jtcvs.2006.02.012
49. Sodha, N. R., Boodhwani, M., Clements, R. T., Feng, J., Xu, S. H., and Sellke, F. W. (2008). Coronary microvascular dysfunction in the setting of chronic ischemia is independent of arginase activity. Microvasc. Res . 75, 238-246. doi: 10.1016/j.mvr.2007.06.008
50. Swamy, M., Salleh, M. J. M., Sirajudeen, K. N. S., Yusof, W. R. W., and Chandra, G. (2010). Nitric oxide (NO), citrulline - NO cycle enzymes, glutamine synthetase and oxidative stress in anoxia (hypobaric hypoxia) and reperfusion in rat brain. Int. J. Med. Sci . 7, 147-154. doi: 10.7150/ijms.7.147
51. +channels. Eur. J. Pharmacol . 712, 16-21. doi: 10.1016/j.ejphar.2013.04.044
52. Van Zandt, M. C., Whitehouse, D. L., Golebiowski, A., Ji, M. K., Thang, M., Beckett, R. P., et al. (2013). Discovery of (R)-2-Amino-6-borono-2-(2-(piperidin-1-1yl)ethyl)hexanoic acid and congeners as highly potent inhibitors of human arginase I and II for treatment of myocardial reperfusion injury. J. Med. Chem . 56, 2568-2580. doi: 10.1021/jm400014c
53. Visigalli, R., Barilli, A., Parolari, A., Sala, R., Rotoli, B. M., Bussolati, O., et al. (2010). Regulation of arginine transport and metabolism by protein kinase Cα in endothelial cells: stimulation of CAT2 transporters and arginase activity. J. Mol. Cell. Cardiol . 49, 260-270. doi: 10.1016/j.yjmcc.2010.04.007
54. Wu, G., and Meininger, C. J. (2000). Arginine nutrition and cardiovascular function. J. Nutr . 130, 2626-2629.
55. Xiong, Y., Yu, Y., Montani, J. P., Yang, Z., and Ming, X. F. (2013). Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its L-arginine ureahydrolase activity: implication for atherosclerotic plaque vulnerability. J. Am. Heart Assoc . 2:e000096 doi: 10.1161/JAHA.113.000096
56. Yagnik, G. P., Takahashi, Y., Tsoulfas, G., Reid, K., Murase, N., and Geller, D. A. (2002). Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology 36, 573-581. doi: 10.1053/jhep.2002.35058
57. Yang, J., Gonon, A. T., Sjöquist, P.-O., Lundberg, J. O., and Pernow, J. (2013). Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity. Proc. Natl. Acad. Sci. U.S.A . 110, 15049-15054. doi: 10.1073/pnas.1307058110
58. Zhang, C., Wu, J., Xu, X., Potter, B. J., and Gao, X. (2010). Direct relationship between levels of TNF-α expression and endothelial dysfunction in reperfusion injury. Basic Res. Cardiol . 105, 453-464. doi: 10.1007/s00395-010-0083-6
59. Zhu, W., Chandrasekharan, U. M., Bandyopadhyay, S., Morris, S. M. Jr. di Corleto, P. E., and Kashyap, V. S. (2010). Thrombin induces endothelial arginase through AP-1 activation. Am. J. Physiol . 298, C952-C960. doi: 10.1152/ajpcell.00466.2009